Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
CompletedNot applicableNCT03000777
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate the effects of oral melatonin plus zinc supplementation in relieving self-reported fatigue in CFS/ME
Study details
- Official title
- An Unicentric, Double-blind, Placebo Controlled, Phase IV Clinical Trial of Oral Melatonin Plus Zinc to Evaluate Relieving Self-reported Fatigue in CFS/ME
- Conditions
- Fatigue Syndrome, Chronic
- Myalgic Encephalomyelitis
- Interventions
- Dietary supplement: melatonin plus zinc
- Other: Placebo
- Sponsor
- Laboratorios Viñas, S.A.
- Collaborators
- Hospital Vall d'Hebron; Laboratorio Echevarne
- Start date
- 2016-02
- Primary completion
- 2017-07
- Sex
- Female
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * CFS patient based on the 1994 Centers for Disease Control and Prevention/Fukuda definition. * Patient who provided signed informed consent. Exclusion Criteria: * Patients who are participating in another clinical trial of the same or different nature previous 30 days prior to inclusion. * Any subject that, in the judgment of the investigator, is not able to follow the instructions or to perform a good completion of the treatment. * Subjects that do not provide signed informed consent. * Patients who are receiving any of the drugs or products that may interfere with the results, and whose withdrawal could be a relevant medical problem. * Patients receiving oral anticoagulants. * Pregnancy or lactation * Patients with hypersensitivity to melatonin and/or zinc.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03000777